OpenAI 2026 hackathon

AgentDoctor Correction Loop

AgentDoctor turns one human correction into targeted evals, repeated regression tests, and a bounded Codex repair goal—so small AI teams can verify fixes without breaking existing behavior.

Solo project by Doris P · 0 likes · 0 comments

Archive position — measured, not model output

0 likes on Devpost

2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #2,399 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

AgentDoctor Correction Loop is a self-reported tool designed for small AI product teams to convert human corrections of agent behavior into targeted evaluations, repeated regression tests, and bounded repair goals. It aims to improve agent reliability by turning production failures into reusable test assets.

What changed

The project description indicates that the team built a correction-driven evaluation loop rather than a static prompt review tool. It introduces a workflow where one human correction becomes a set of frozen evaluation cases, repeated regression tests, and a narrowly scoped repair task.

Single most important open question — the commercial due-diligence read

Is there evidence of real-world usage or adoption by AI teams? The description is entirely self-reported and lacks any data on revenue, customers, product usage, or traction beyond a demo.

Back to contents

What The Product Actually Is

The description states that AgentDoctor Correction Loop helps small AI teams determine whether an agent fix works without breaking existing behavior. It captures failures and human corrections, diagnoses the failure using GPT-5.6, generates targeted evaluations, runs repeated regression tests, produces an evidence-based verdict, and creates a bounded Codex repair goal.

Inference The system appears to be a prototype or demo focused on QA-agent scenarios, with no automatic repository editing capability in its current version.

Back to contents

Positioning & Claim Evolution

The description states that AgentDoctor turns one human correction into targeted evals, repeated regression tests, and a bounded Codex repair goal. It positions itself as a way for small AI teams to verify fixes without breaking existing behavior.

Inference It is positioned as a reliability tool for AI agents, not a general-purpose LLM evaluation platform or prompt engineering tool.

Back to contents

Target Customer & ICP

The description states that AgentDoctor targets “small AI product teams.” It also notes that the current public demo intentionally uses a narrow QA-agent scenario so that every conclusion can be inspected.

Inference The target customer is likely small to mid-sized AI product teams working on agent-based systems, particularly those in early-stage development or testing phases.

Back to contents

Business Model & Pricing Evidence

Not evidenced. The description does not mention any pricing model, monetization strategy, or business model.

Back to contents

Technical & Delivery Signals

The system uses GPT-5.6 for diagnosis and is built with technologies including Next.js, React, Node.js, Tailwind, TypeScript, Vercel, OpenAI, and Codex. It generates frozen evaluation cases and runs repeated tests against baseline and candidate versions.

Inference It appears to be a prototype or demo tool focused on QA-agent workflows, not a production-ready SaaS offering.

Back to contents

Traction & Maturity Signals

Not evidenced. There is no mention of revenue, customers, user base, or product adoption beyond the demo.

Back to contents

Competitive Context

Not evidenced. The description does not reference competitors or market positioning in relation to other tools for AI agent reliability or testing.

Back to contents

Key Risks & Red Flags

  • No evidence of real-world usage or traction: The entire description is self-reported and lacks any data on adoption.
  • Demo-only scope: The current version only demonstrates the evaluation and regression loop, not full automation or repository editing.
  • Unproven scalability: The system is built around a narrow QA-agent scenario; no indication it scales beyond that.
  • No commercial viability signal: No pricing, monetization, or business model described.

Back to contents

Diligence Questions To Ask The Founders

  1. What real-world feedback or use cases drove the development of this tool?
  2. Has the system been tested with actual AI agents in production environments?
  3. Are there any plans to integrate with existing CI/CD or repository systems?
  4. How does the team plan to scale beyond the current demo scenario?
  5. What is the long-term vision for monetization and product development?

Back to contents

Investment/Partnership Verdict

Not evidenced. The description provides no information on valuation, funding rounds, or investment history. It also lacks any indication of commercial traction or market readiness.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.